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Introduction {#sec005}
============

When it comes to controlling blood glucose levels and establishing euglycaemia in diabetes, the probably most important factor is patients' self-management of the condition \[[@pone.0150774.ref001]--[@pone.0150774.ref003]\]. Since poor glycaemic control contributes greatly to the risk of developing serious long-term complications of diabetes \[[@pone.0150774.ref004]--[@pone.0150774.ref007]\], the improvement of relevant self-management behaviours can be an important key to improved diabetes prognosis and reduced risks of long-term complications.

For clinicians seeking to assess their patients' diabetes self-management and detect potential areas in need of improvement, a standardised psychometric assessment tool which provides reliable and valid assessments of the essential domains of diabetes self-management can be a valuable tool. For researchers who need to measure diabetes self-management as part of a study, a standardised tool may be key. It is therefore not surprising that over the last three decades a variety of self-report measures concerning diabetes self-management have been developed. A recent systematic review identified a total of 21 multidimensional scales of overall diabetes self-management plus some additional ones focussing on single self-management domains, originating from various countries \[[@pone.0150774.ref008]\]. However, despite this seeming abundance of measurement options, the number of useful and psychometrically satisfactory instruments is indeed limited. Moreover, not all of the tools reviewed in the paper are at all accessible. Out of the 21 scales, only ten were available in English language, and out of those, only five were rated sufficiently validated by the reviewing authors \[[@pone.0150774.ref008]\]. This result clearly corresponds to two earlier reviews on the topic which collected a total of five \[[@pone.0150774.ref009]\] and seven \[[@pone.0150774.ref010]\] self-management scales, respectively.

One of the few instruments to satisfy comprehensive psychometric appraisal is the Summary of Diabetes Self-Care Activities Measure (SDSCA). It is in fact the only scale judged positively by all three reviews, and although not free from weaknesses \[[@pone.0150774.ref008],[@pone.0150774.ref010]\], it is the only tool which met the rigorous appraisal criteria of the review by Eigenmann et al. \[[@pone.0150774.ref009]\]. Moreover, the SDSCA has gained the status of a standard measure, similar to a gold standard, since its development in 1993 and revision in 2000 \[[@pone.0150774.ref011],[@pone.0150774.ref012]\], as it is the most commonly used research tool to assess diabetes self-management today \[[@pone.0150774.ref009],[@pone.0150774.ref013]\]. Its efficiency and economy with no more than eleven items to cover five essential self-management domains--general diet, specific diet, exercise, blood-glucose testing and foot care--has proven to be appealing to both researchers and clinicians.

However, the SDSCA has several limitations, the most important one being a poor association with levels of glycaemic control. In fact, an absence of significant associations between self-management behaviours as measured by the SDSCA and HbA~1c~ was already reported in the scale's initial evaluation \[[@pone.0150774.ref011]\]; subsequent studies supported this result with findings of generally low associations between the SDSCA and HbA~1c~ \[[@pone.0150774.ref013]--[@pone.0150774.ref018]\]. This limitation is problematic for two reasons: 1) Since we assume that better self-management (e. g. adjusting diet; testing blood glucose; taking required medications) should lead to better glycaemic control, a weak association between these variables raises concerns regarding the measure's validity. 2) Such a weak association limits the measure's practical utility for both clinicians and researchers. For example, a number of studies aimed to analyse the impact of psychosocial factors such as depression, which is supposed to cause reduced glycaemic control through disregard of diabetes self-management, on these outcomes in comprehensive regression or structural equation model analyses \[[@pone.0150774.ref017]--[@pone.0150774.ref020]\]. However, studies using the SDSCA were usually inconclusive \[[@pone.0150774.ref017]--[@pone.0150774.ref020]\], which appears comprehensible when keeping the weak associations with HbA~1c~ in mind. When seeking to understand self-reported behavioural causes of hyperglycaemia in a patient or when aiming to analyse aspects of self-management and glycaemic control in studies, a measurement tool with good predictive power of glycaemic outcomes is to be preferred.

A relatively new psychometric tool to assess diabetes self-management is the Diabetes Self-Management Questionnaire (DSMQ), introduced in 2013 \[[@pone.0150774.ref021]\]. The scale covers several important domains--diet, medication, blood glucose monitoring, physical activity and contact with health-care professionals--and particularly focusses on activities related to glycaemic control. It was thoroughly evaluated and has since then been used in studies in Germany \[[@pone.0150774.ref022]--[@pone.0150774.ref024]\], the UK \[[@pone.0150774.ref025],[@pone.0150774.ref026]\] and the US \[[@pone.0150774.ref027]--[@pone.0150774.ref029]\], i. a. However, it was not included in any of the aforesaid reviews due to its relative novelty. There is evidence of above-average convergence between the self-management behaviours measured by the DSMQ and glycaemic control. This suggests good eligibility and utility of this tool either for analysing behavioural problems related to hyperglycaemia in clinical practice or for testing putative mediation of the effect of a given factor on glycaemic control by diabetes self-management.

Following this evidence, we planned to rigorously test the DSMQ as a statistical predictor of glycaemic control in patients with type 1 and type 2 diabetes using structural equation modelling. We hypothesized to find significantly greater predictive power (i. e. linear association with HbA~1c~ and explanation of glycaemic variation, respectively) by diabetes self-management as measured using the DSMQ compared to self-management as measured using the common standard, SDSCA.

Material and Methods {#sec006}
====================

Data acquisition was performed as part of a larger study, approved by the Ethics Committee of the State Medical Chamber of Baden-Wuerttemberg. A cross-sectional convenience sample of 430 patients with type 1 or type 2 diabetes was enrolled at a referral centre for people with diabetes in Germany (Diabetes Center Mergentheim). Inclusion criteria were adult age (≥ 18 years), diabetes type 1 or type 2, sufficient language skills and written informed consent. Exclusion criteria were terminal illness, being bedbound and being under guardianship (based on patient records). Patients eligible for study participation were approached during their 10 to 12 days stay at the centre, informed about the study and invited to participate. The participation rate amounted to 62%. Study participants were assessed using the DSMQ and SDSCA. HbA~1c~ was analysed in the centre's laboratory simultaneously with the questionnaire assessments. Demographic data were collected in interviews conducted by the centre's nurses. Long-term complications were diagnosed by the centre's physicians.

Instruments and Measures {#sec007}
------------------------

### Diabetes Self-Management Questionnaire (DSMQ) {#sec008}

The DSMQ consists of 16 items covering five different aspects of diabetes self-management. All items are formulated as behavioural descriptions from the person's point of view (examples below). Respondents rate the extent to which each description applies to them on a four-point Likert scale (3 --'applies to me very much' to 0 --'does not apply to me'), referring to the previous eight weeks (full contents are provided in [S1 Table](#pone.0150774.s002){ref-type="supplementary-material"}). Item scores are transformed so that higher scores indicate more desirable self-management behaviour (requiring reverse-scoring of negatively-keyed items) and summed/transformed to five scale scores with ranges from 0 to 10 (scoring is explained in detail elsewhere \[[@pone.0150774.ref021]\]). The scales reflect patients' *dietary control* (4 items; e.g. 'The food I choose to eat makes it easy to achieve optimal blood sugar levels'), *medication adherence* (2 items; e.g. 'I tend to forget or skip my diabetes medication'), *blood glucose monitoring* (3 items; e.g. 'I check my blood sugar levels with care and attention'), *physical activity* (3 items; e.g. 'I am less physically active than would be optimal for my diabetes') and *physician contact* (3 items; e.g. 'I keep all doctors' appointments recommended for my diabetes treatment'). Its validation study supported the DSMQ's reliability and validity \[[@pone.0150774.ref021]\]; in the present study, reliability coefficients were observed as follows (Cronbach's *α*; stratified by scale): dietary adherence 0.79; medication adherence 0.75; blood glucose monitoring 0.83; physical activity 0.74; appointment adherence 0.72.

### Summary of Diabetes Self-Care Activities Measure (SDSCA) {#sec009}

The SDSCA is a standard self-report scale to assess diabetes self-management. Ten items assess the frequencies of specific self-management activities during the previous week; an additional item assesses smoking. Respondents mark the numbers of days (0--7) on which the indicated behaviours were performed. The item scores can be averaged to the five subscales *general diet* (2 items; e.g. 'How many of the last seven days have you followed a healthful eating plan?'), *specific diet* (2 items; e.g. 'On how many of the last seven days did you eat five or more servings of fruits and vegetables?'), *exercise* (2 items; e.g. 'On how many of the last seven days did you participate in at least 30 minutes of physical activity?'), *blood-glucose testing* (2 items; e.g. 'On how many of the last seven days did you test your blood sugar?') and *foot care* (2 items; e.g. 'On how many of the last seven days did you check your feet?'). All scale scores range from 0 to 7 with higher scores suggesting better self-management. The SDSCA has shown adequate reliability and validity in English \[[@pone.0150774.ref012]\] as well as German samples \[[@pone.0150774.ref013]\]; in this study, reliability coefficients were observed as follows (Cronbach's *α*; stratified by scale): general diet 0.89, specific diet 0.30, exercise 0.74, blood-glucose testing 0.78, foot care 0.72.

### Commonalities and differences of the DSMQ and the SDSCA {#sec010}

When comparing the DSMQ and SDSCA, there is significant overlap in contents with regard to the aspects diet, exercise/activity and self-monitoring of blood glucose. Nevertheless, the measurement approach is different since the SDSCA requests numbers of days per last week on which a particular behaviour was performed. Hence, the appraisal of good versus poor self-management lies in the hands of the professional and must be based on the patient's individual regimen. By contrast, the DSMQ involves the self-rating of self-management by the patient, and rating is done with regard to a more general time period of eight weeks. Results may be more representative but potentially also more susceptible to memory bias. Furthermore, the DSMQ comprises items on medication intake and contact to one's physician--aspects which were considered relevant regarding glycaemic control when developing the scale. In its earlier version, the SDSCA also included an item on medication, but this was excluded due to psychometric limitations when the scale was revised to its current form in 2000 \[[@pone.0150774.ref012]\]. On the other hand, the SDSCA includes foot care and smoking behaviours, which represents a relevant difference to the DSMQ. In sum, the two scales differ significantly regarding assessed timeframe, item formulation and item content.

### Glycated haemoglobin {#sec011}

As a measure of patients' glycaemic control, glycated haemoglobin (HbA~1c~) was assessed. This measure reflects a patient's average blood glucose levels during the previous two to three months \[[@pone.0150774.ref030]\]. All blood samples were analysed in a central laboratory at the same time point as the questionnaire assessment were conducted (i. e. assessments were made within one to seven days apart from each other, on average about three days). HbA~1c~ was determined using high performance liquid chromatography (HPLC) performed with the Bio-Rad Variant II Turbo analyser (meeting the requirements of current standards of HbA~1c~ measurements; DCCT standard). The laboratory normal range is 4.3--6.1% (23.5--43.2 mmol/mol).

Statistical Analyses {#sec012}
--------------------

The statistical analyses were performed using SPSS 22.0.0 including AMOS 22.0.0 (IBM SPSS Statistics, New York, USA). A *P* value \< 0.05 was considered as criterion of statistical significance in all analyses. Structural equation modelling was performed using maximum likelihood estimation. The basic test model included the variables HbA~1c~ and diabetes self-management with the latter being modelled as latent variable operationalised by either the DSMQ's or SDSCA's five self-management behaviours (see Figs [1](#pone.0150774.g001){ref-type="fig"} and [2](#pone.0150774.g002){ref-type="fig"}). This approach enabled the integration of the heterogeneous behaviours in a single variable of diabetes self-management, while the individual behaviours were weighted based on the fit to the data. As a result, the structural equation modelling warranted optimal predictive power of diabetes self-management as operationalised by the DSMQ or SDSCA behaviours regarding glycaemic control.

![Stuctural equation model of diabetes self-management as measured by the DSMQ and glycaemic control for patients with type 1 and type 2 diabetes.\
Data are standardised regression weights (*β*) for paths or squared multiple correlations (*R*^2^) for variables. Boxes indicate manifest measurement variables; ovals indicate latent variables operationalised by manifest indicators; error terms are not displayed for ease of presentation. SRMR, Standardised Root Mean Square Residual; TLI, Tucker Lewis Index; CFI, Comparative Fit Index; RMSEA, Root Mean Square Error of Approximation. Indication of two-sided significance: \* *P* \< 0.05; † *P* \< 0.01; ‡ *P* \< 0.001.](pone.0150774.g001){#pone.0150774.g001}

![Stuctural equation model of diabetes self-management as measured by the SDSCA and glycaemic control for patients with type 1 and type 2 diabetes.\
Data are standardised regression weights (*β*) for paths or squared multiple correlations (*R*^2^) for variables. Boxes indicate manifest measurement variables; ovals indicate latent variables operationalised by manifest indicators; error terms are not displayed for ease of presentation. SRMR, Standardised Root Mean Square Residual; TLI, Tucker Lewis Index; CFI, Comparative Fit Index; RMSEA, Root Mean Square Error of Approximation. Indication of two-sided significance: \* *P* \< 0.05; † *P* \< 0.01; ‡ *P* \< 0.001.](pone.0150774.g002){#pone.0150774.g002}

The resulting models were tested on people with type 1 and type 2 diabetes separately, each being revised by successively modelling correlations between the variables' error terms, following significant modification indices (threshold = 4.0) in order to attain adequate fit of the models. Model fit was evaluated according to the recommendations by Hu and Bentler \[[@pone.0150774.ref031]\]: Standardised Root Mean Square Residual (SRMR) ≤ 0.08, Tucker Lewis Index (TLI) ≥ 0.95, Comparative Fit Index (CFI) ≥ 0.95 and Root Mean Square Error of Approximation (RMSEA) ≤ 0.06 (with upper bound of the 90% CI ≤ 0.08). The fitted models were used to evaluate the predictive power of the DSMQ and SDSCA regarding HbA~1c~ (assessed by the explanation of variance, i. e. squared multiple correlation, of HbA~1c~). Differences between standardised regression coefficients were tested for statistical significance using Steiger's *z*-test of the difference between dependent correlations. To account for potential confounding effects, the models were additionally analysed while adjusting for gender and age.

Evaluations of the self-report data's distribution characteristics revealed non-normal distributions in three of the DSMQ scales (medication adherence, blood glucose monitoring and appointment adherence) and three of the SDSCA scales (exercise, blood-glucose testing and foot care). To ensure adequate normality, all scale scores were converted using Templeton's two-step method for transforming continuous variables to normal \[[@pone.0150774.ref032]\]. The procedure involves a first step of percentile rank transformation, resulting in uniformly distributed probabilities, followed by a second step applying the inverse-normal transformation in order to form variables consisting of normally distributed *z*-scores.

Results {#sec013}
=======

Sample description {#sec014}
------------------

The sample characteristics are displayed in [Table 1](#pone.0150774.t001){ref-type="table"}. The total sample comprised 248 patients with type 1 diabetes (58%) and 182 patients with type 2 diabetes (42%).

10.1371/journal.pone.0150774.t001

###### Characteristics of the study sample.

![](pone.0150774.t001){#pone.0150774.t001g}

                                                                  Total sample   Type 1 DM     Type 2 DM
  --------------------------------------------------------------- -------------- ------------- -------------
  *Demographic variables*:                                                                     
  Female gender                                                   233 (54.2%)    149 (60.1%)   84 (46.2%)
  Age (years)                                                     46.6 ± 14.6    39.0 ± 13.2   57.0 ± 8.9
  BMI (kg/m^2^)                                                   30.0 ± 10.0    26.9 ± 11.0   34.1 ± 6.6
  *Diabetes-related variables*:                                                                
  Diabetes duration (years)                                       15.3 ± 10.5    16.6 ± 12.1   13.5 ± 7.5
  Diabetes treatment:                                                                          
  Insulin treatment                                               393 (91.4%)    248 (100%)    146 (80.2%)
  Other medical treatment[^a^](#t001fn002){ref-type="table-fn"}   37 (8.6%)      0 (0%)        36 (19.8%)
  HbA~1c~:                                                                                     
  Value in %                                                      8.5 ± 1.6      8.5 ± 1.6     8.6 ± 1.5
  Value in mmol/mol                                               70 ± 17        70 ± 18       70 ± 17
  Patients with values \> 7.5% (59.5mmol/mol)                     308 (71.6%)    176 (71.0%)   132 (72.5%)
  Long-term complications:                                                                     
  Retinopathy                                                     100 (23.3%)    57 (23.0%)    43 (23.6%)
  Neuropathy                                                      123 (28.6%)    36 (14.5%)    87 (47.8%)
  Nephropathy                                                     44 (10.2%)     11 (4.4%)     33 (18.1%)
  Foot ulcer                                                      23 (5.3%)      5 (2.0%)      18 (9.9%)

Data are *n* (%) or M ± SD. BMI, Body Mass Index; HbA~1c~, glycated haemoglobin; M, mean; SD, standard deviation.

^a^ oral antidiabetic agents and/or incretin mimetics.

Patients with type 1 diabetes had a mean (± SD) age of 39 (± 13) years; the mean BMI was 27 (± 11) kg/m^2^, and with a prevalence of 60%, females were slightly overrepresented. Glycaemic control was clearly improvable as 71% of the patients had HbA~1c~ values above 7.5% (59.5 mmol/mol) (the criterion for adequate glycaemic control suggested by the German Diabetes Association). 31% were diagnosed with one or more long-term complications.

Patients with type 2 diabetes were on average 57 (± 9) years old and had a mean BMI of 34 (± 7) kg/m^2^. With a rate of 46% of the sample being female, the gender distribution was relatively balanced. The majority of patients (80%) were treated with insulin, corresponding to the rather long illness duration of 14 (± 8) years. Glycaemic control was comparable to that of the type 1 diabetes group; approximately 73% had HbA~1c~ values above 7.5% (59.5 mmol/mol). Long-term complications were present in 62% of the patients.

Structural equation model of diabetes self-management as measured by the DSMQ {#sec015}
-----------------------------------------------------------------------------

The structural equation model of diabetes self-management as measured by the DSMQ is displayed in [Fig 1](#pone.0150774.g001){ref-type="fig"}. The model showed very good fit for both type 1 and type 2 diabetes (see [Fig 1](#pone.0150774.g001){ref-type="fig"}), and all regression weights were significant with *P* \< 0.001. Diabetes self-management as operationalised by the DSMQ's behaviour scales showed a notable negative association with HbA~1c~ amounting to --0.53 (*P* \< 0.001) for people with type 1 diabetes and --0.46 (*P* \< 0.001) for people with type 2 diabetes. The squared multiple correlations for these associations were 0.276 and 0.213, respectively, equalling an explanation of 27.6% of glycaemic variation for patients with type 1 and 21.3% of variation for those with type 2 diabetes. Most relevant DSMQ behaviours with regard to glycaemic control were blood glucose monitoring, medication adherence and dietary control for both diabetes types, whereas physician contact and physical activity appeared less relevant in this regard (see [Fig 1](#pone.0150774.g001){ref-type="fig"}). Adjusting the model for potential confounding effects of demographic variables did not appreciably alter these results.

Structural equation model of diabetes self-management as measured by the SDSCA {#sec016}
------------------------------------------------------------------------------

The structural equation model of diabetes self-management as measured by the SDSCA is displayed in [Fig 2](#pone.0150774.g002){ref-type="fig"}. The model showed very good fit for both diabetes types (see [Fig 2](#pone.0150774.g002){ref-type="fig"}), and all regression weights were significant with *P* \< 0.01. Diabetes self-management as operationalised by the SDSCA's behaviour scales showed a significant negative association with HbA~1c~ of --0.14 (*P* = 0.030) for type 1 diabetes and --0.31 (*P* = 0.003) for type 2 diabetes. The squared multiple correlations between self-management and HbA~1c~ were 0.019 and 0.099, respectively, equalling an explanation of roughly 2% of glycaemic variation for type 1 diabetes and 10% of variation for type 2 diabetes. Most relevant SDSCA behaviours with regard to glycaemic control were general and specific diet as well as blood glucose testing. As was the case with the corresponding DSMQ scale, exercise was less relevant regarding the glycaemic outcome (see [Fig 2](#pone.0150774.g002){ref-type="fig"}). Adjusting the model for potential confounding effects of demographic variables did not appreciably alter these results.

Testing the differences between associations for statistical significance {#sec017}
-------------------------------------------------------------------------

Steiger's *z*-test was used to test if the differences between the associations of diabetes self-management as measured by the DSMQ versus SDSCA with HbA~1c~ were statistically significant. The comparison yielded *z*-scores of 10.10 for type 1 and 3.39 for type 2 diabetes, indicating significantly stronger associations between the DSMQ self-management scores and HbA~1c~ compared to those of the SDSCA for both type 1 and 2 diabetes (both *P* \< 0.001).

Discussion {#sec018}
==========

Testing the DSMQ as a statistical predictor of the glycaemic control of patients with type 1 and type 2 diabetes yielded a number of notable findings: First, diabetes self-management as measured by the DSMQ's self-management behaviours was indeed strongly related to glycaemic control as reflected by HbA~1c~, in total explaining between 21 and 28 percent of glycaemic variation. This finding suggests that the DSMQ may be a valuable assessment tool for professionals who seek to understand causes of hyperglycaemia in patients by evaluating their self-management behaviours. Second, the associations between self-management as measured by the DSMQ were significantly stronger than the equivalent ones for the SDSCA, and the amount of glycaemic variation explained by the DSMQ's measurement was in fact about twice that of the SDSCA. However, since not all aspects assessed by the latter scale can be assumed to predict glycaemia (e. g. foot care, smoking), this result does not necessarily have to devalue the widely used SDSCA. Nevertheless, it constitutes evidence that when focussing self-management in relation to glycaemic control, the DSMQ should be the measurement of choice. Third, using structural equation modelling for our analyses enabled the integration of heterogeneous self-management behaviours into a single variable of self-management, while weighting the behaviours with regard to their relevance for glycaemic control. Hence, we were able to analyse which behaviours of the DSMQ and SDSCA had a greater impact on the glycaemic outcome. While self-management based on the SDSCA had its highest beta coefficients in dietary behaviours, while other aspects appeared less relevant, self-management as based on the DSMQ showed strong associations not only regarding diet but also blood glucose monitoring and medication adherence. Since these behaviours can be expected to impact on the glycaemic control of people with both type 1 and type 2 diabetes, these differences between the two scales may account for their unequal predictive power regarding HbA~1c~.

Our results also support the DSMQ as a measurement tool of choice in studies aiming to analyse potential impact of specific factors of interest (e. g. depression) on diabetes self-management and glycaemic control using structural equation modelling, as often intended \[[@pone.0150774.ref017]--[@pone.0150774.ref020]\]. Good model fit, valid operationalisation of self-management by the DSMQ's behaviour scales and good convergence with HbA~1c~ suggest that a structural equation model analysis of the impact of depression on glycaemic control via self-management, as conducted for example by Lustman et al. \[[@pone.0150774.ref017]\], might potentially produce more conclusive results when using the DSMQ compared to the SDSCA.

Without a doubt, there are several alternative measures besides these two scales. Some of those have shown promising properties supporting their usability \[[@pone.0150774.ref008]--[@pone.0150774.ref010]\]. However, overall bivariate correlations between the DSMQ and HbA~1c~ with values between --0.40 and --0.43 \[[@pone.0150774.ref021],[@pone.0150774.ref022]\] appear to lie above the average of such correlations observed for most analogous instruments. Studies reporting on this aspect usually found associations of small to moderate sizes \[[@pone.0150774.ref010]\], specifically between --0.10 and --0.26 for the SDSCA \[[@pone.0150774.ref021],[@pone.0150774.ref013]\], between --0.16 and --0.37 for the Self-Care Inventory \[[@pone.0150774.ref033]--[@pone.0150774.ref035]\], and around --0.33 for the Diabetes Care Profile \[[@pone.0150774.ref036]\]. Of course, however, direct comparisons between those scales would be required to comparatively evaluate their properties.

Three independent reviews raised concerns against many available tools and encouraged the establishment of more appropriate ones \[[@pone.0150774.ref008]--[@pone.0150774.ref010]\]. Against this background, we consider the findings of this present study--supporting the DSMQ's reliable and valid use to assess diabetes self-management in relation to glycaemic control--very promising.

There are some limitations of our study, primarily related to background and composition of the analysed convenience sample collected at a diabetes referral centre as well as the study's cross-sectional nature. Patients are usually referred to this diabetes centre for problems of diabetes control, which is confirmed by the sample characteristics. The centre's typical patient composition comprises up to 60% of patients with type 1 diabetes, and the majority of patients with type 2 diabetes is treated with insulin; both patient groups typically live with the condition for many years. Hence, the presented sample may not be generalisable for primary care settings. On the other hand, it is particularly this population in which the measurement of diabetes self-management to identify behavioural factors linked to poor glycaemic control may be desired. Since the data base for our study was cross-sectional, inferences of causal relationships between the assessed variables are not valid.

The strengths of the study lie in the standardised assessments (in-patient setting; psychometric assessment using standardised scales; blood sampling within few days apart from psychometric assessments; HbA~1c~ analysis in one central laboratory) as well as the sample composition comprising patients with both type 1 and type 2 diabetes, enabling generalisation for both major diabetes types.

In summary, this study supports the DSMQ as preferable tool when analysing behavioural problems related to reduced glycaemic control. The scale may be useful for clinical assessments of patients with suboptimal glycaemic outcomes or research on factors concerning associations between self-management behaviours and glycaemic control.
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